• Topics

  • Formats

Organiser: The MSL

Author(s): 

Medical affairs (MA) serves as a bridge across various business units in a company and plays a crucial role to improve patient’s outcome by engaging with external stakeholders. In contrast to other business units, such as sales, the measurement of the impact of MA and their field medical (FM) personnel such as the medical science liaisons (MSLs) is still highly debated in the community as key performance indicators (KPIs) such as activity metrics are mostly adapted from commercial performance measurements that might not adequately represent the impact of MA. Although recent literature (see below) suggests a much more holistic approach to measure the impact of FM and their MSLs, this article focuses on the conundrum of how the industry is split in considering activity metrics and why it is sensible to maintain it.

As shown by a report from 2023 “Measuring the Impact of Medical Affairs”1,a survey of FM leaders elucidated a disparity between the priority of key outcome metrics that FM leaders considered important and what their team was measuring. The results show that activity metrics was the main measured KPI (35%) although FM leaders considered this KPI as one of the least relevant (6%). Moreover, the report suggests a “medical impact model” whose foundation is based on operational effectiveness to fulfill other metrics that are more HCP and patient centered. Operational effectiveness might be viewed as either to be aligned to activity metrics such as frequent contacts to ensure a certain level of impact on HCP and patients or not to be affected by frequent visits due to lack of knowledge about the exchange; a further recent report from 2024 named “Field medical impact measurement: A biopharma consensus”2 aimed to create novel Field Medical Impact Indicators (FMIIs) to assess the impact and value of FM roles. The report states that activity metrics such as frequency of contact with HCPs do not necessarily parallel the impact or even value created by MSLs (definitions of “impact” and “value” can be found in the report). Thus, MA and their MSLs need to consider other objectives of their role and functions to fulfill expectations of HCPs, patients, and even their own company.

Reading this content is completely free

Enjoy Unlimited Access and Unlock
Additional Features with a Free Account

Join Now

You are attempting to log out of MyMA

Do you really want to log out?